DT120, an orally disintegrating LSD tablet, is in three Phase III trials (two for GAD, one for MDD) with Breakthrough Therapy designation; the MDD study (Emerge) is fully enrolled and expected to read ...
Dr Phil Birch discusses adaptive design in clinical trials and how the clinical development landscape is evolving. The interplay between innovative statistical methodology, smart trial execution ...
The aim of this contribution is to explain in a straightforward manner how Bayesian inference can be used to identify material parameters of material models for solids. Bayesian approaches have ...
Outline In this tutorial I am going to present the use of the Species Network model (Zhang et al. 2017), which is implemented as an add-on package for BEAST2 (Bouckaert et al. 2014) and allows the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results